𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
banner
entessarly204.bsky.social
𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
@entessarly204.bsky.social
Physician
GI & Hepatology Department
Tripoli University Hospital
Tripoli _Libya
March 30, 2025 at 6:26 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
I learned that several patients in our practice have had their carvedilol prescriptions refused by the pharmacist because it is contraindicated in cirrhosis

1. No
2. Please talk to the doctor / prescriber before saying something like this to a patient

#liversky
February 13, 2025 at 2:13 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
🔥🔥🔥BREAKWATER🔥🔥🔥

BRAF V600E mut #CRC

SOC (FOLFOX) +/- encorafenib + cetuximab

EC + FOLFOX shows:

✅⬆️ORR
✅Strong suggestion of ⬆️OS

🚨EC + FOLFOX is a new SOC‼️

Pub available: idp.nature.com/authorize?re...

#GI25 @ascocancer.bsky.social
January 25, 2025 at 11:11 PM
Winter ❄️🥶
Tripoli - Libya
December 25, 2024 at 11:39 AM
Tripoli _Libya
December 8, 2024 at 9:29 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
🧪 New research on PSC-IBD & IBD:

- 1 in 50 new IBD cases involves PSC-IBD & diagnosis is rising in higher socioeconomic groups
- IBD diagnosis before PSC has worse outcomes than diagnosis w/ PSC first
- Higher rates of death & transplant in PSC-IBD vs IBD alone
www.jhep-reports.eu/article/S258...
DEFINE_ME
www.jhep-reports.eu
December 5, 2024 at 3:21 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
(2/2) Cholangiocarcinoma - Klastkin type

Scroll through the case on Radiopaedia: radiopaedia.org/play/76428/e...

#Radsky #Medsky #FOAMrad #radiology
November 26, 2024 at 2:52 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
Seven shades of melaena!
It is often frustrating when we get dubious GI referrals for suspected melaena/melena. So I made this chart for reference, feel free to share! #medsky #gastrosky #gisky
November 29, 2024 at 10:21 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
Ok #GastroSky #IBDSky

Let’s discuss this paper!

Does VDZ become the drug of choice over anti-TNFs for prevention of post of CD recurrence?

Should history of previous biologic failure for active CD affect you choice of post-op prophylaxis?

REPOST to share to the IBD community, patient input pls!
Vedolizumab to prevent postoperative recurrence of Crohn's disease (the REPREVIO RCT)

"Vedolizumab prevented postoperative recurrence of CD & should be considered as a prophylactic treatment in individuals with risk factors for recurrence."

www.thelancet.com/journals/lan...

#GastroSky #IBDSky
November 19, 2024 at 2:54 PM
November 27, 2024 at 4:27 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
Hello IBDers - I put together this table of Crohn's and UC medication, according to whether you take the drug orally, by injection or by infusion.

May be useful if you have a preference for how you receive your #IBD meds. Based on UK prescribing only.

#IBDsky ##GastroSky #GISky
November 25, 2024 at 5:36 PM
أحيانا أريد فقط أن أكون بعيداً عن كل شيء .
Sometimes I just want to get away from it all.
November 21, 2024 at 8:09 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
Great look into the future on HCC surveillance by George Ioannou at AASLD #TLM24

Seems likely that blood based biomarkers and aMRI will play some role but, despite its significant flaws, ultrasound has so far stood the test of time
November 16, 2024 at 2:45 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
Brilliant thread on hospital induced anaemia.
Still ordering daily labs? Let’s talk about phlebotomy and hospital-acquired anemia.

Reports from 1970-2000s suggested that pts were losing 25-50 ml/day to phlebotomy; about a unit of blood each week.

We must be better today, right?

1/x

#anemia #medsky #ansky #emimcc
November 18, 2024 at 8:25 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
Pearls from « Viral Hepatitis and Immunosuppression : When to Screen and When to Treat »

#TLM24 #Liversky #IDsky

➡️ Screening Recommendations for prevention of HBV reactivation

(no current recommendations for any other viral hepatitis screening)

Use triple panel test
= HBsAg, HBcAb, HBsAb
November 18, 2024 at 7:49 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
🧪 Researchers identify 3 subtypes of metabolic-associated steatotic liver disease ( #MASLD - old term #NAFLD ) in a Chinese cohort

🔑The 3 subtypes have differential risks of developing cirrhosis and HCC

🎯Subtypes could aid in personalized treatment

#LiverSky

www.science.org/doi/abs/10.1...
Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population
Integrative multiomic analysis identifies three molecular subtypes of NAFLD associated with distinct clinical risks.
www.science.org
November 18, 2024 at 7:31 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
Some good epidemiology

Risk of liver events in people with compensated cirrhosis #tlm24
November 16, 2024 at 11:29 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
I know I'm a bit late, but here's the updated table of #IBD treatments with their doses & routes of administration with the addition of guselkumalb

Full quality table ➡️ www.ibd-eii.com/ibdcheatsheet/
November 17, 2024 at 4:47 PM
Reposted by 𝓔𝓷𝓽𝓮𝓼𝓼𝓪𝓻 𝓐. 𝓜𝓮𝓮𝓵𝓪𝓭🩺
2/2 EUS guided gallbladder drainage for a nonsurgical candidate with cholecystitis. #gastro #gastroenterology #endoscopy
November 17, 2024 at 2:48 AM